The cardiologist points out that nobody has settled on what microdosing a GLP-1 actually means, and she goes into it further in her Substack this week.
Recap by typeshit. Post by @drjennhaythe on Instagram.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
A piece on questions about tirzepatide and breast cancer risk. Only the headline is available, so check the source for what the evidence says.
Holyfield claims the muscle share of weight lost on retatrutide matches what the body defaults to with plain calorie cutting. His take, not a verified figure.
Dr Zack points to critics who attack physicians while wholesaling unlicensed research peptides that lack FDA approval.
Loading…